Literature DB >> 19188248

A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions.

Adam J Rose1, Thomas J Alsted, Thomas E Jensen, J Bjarke Kobberø, Stine J Maarbjerg, Jørgen Jensen, Erik A Richter.   

Abstract

Skeletal muscle protein synthesis rate decreases during contractions but the underlying regulatory mechanisms are poorly understood. It was hypothesized that there would be a coordinated regulation of eukaryotic elongation factor 2 (eEF2) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1) phosphorylation by signalling cascades downstream of rises in intracellular [Ca(2+)] and decreased energy charge via AMP-activated protein kinase (AMPK) in contracting skeletal muscle. When fast-twitch skeletal muscles were contracted ex vivo using different protocols, the suppression of protein synthesis correlated more closely with changes in eEF2 than 4EBP1 phosphorylation. Using a combination of Ca(2+) release agents and ATPase inhibitors it was shown that the 60-70% suppression of fast-twitch skeletal muscle protein synthesis during contraction was equally distributed between Ca(2+) and energy turnover-related mechanisms. Furthermore, eEF2 kinase (eEF2K) inhibition completely blunted increases in eEF2 phosphorylation and partially blunted (i.e. 30-40%) the suppression of protein synthesis during contractions. The 3- to 5-fold increase in skeletal muscle eEF2 phosphorylation during contractions in situ was rapid and sustained and restricted to working muscle. The increase in eEF2 phosphorylation and eEF2K activation were downstream of Ca(2+)-calmodulin (CaM) but not other putative activating factors such as a fall in intracellular pH or phosphorylation by protein kinases. Furthermore, blunted protein synthesis and 4EBP1 dephosphorylation were unrelated to AMPK activity during contractions, which was exemplified by normal blunting of protein synthesis during contractions in muscles overexpressing kinase-dead AMPK. In summary, in fast-twitch skeletal muscle, the inhibition of eEF2 activity by phosphorylation downstream of Ca(2+)-CaM-eEF2K signalling partially contributes to the suppression of protein synthesis during exercise/contractions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188248      PMCID: PMC2678225          DOI: 10.1113/jphysiol.2008.167528

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  64 in total

1.  Why muscle stops building when it's working.

Authors:  Michael J Rennie
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

2.  Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.

Authors:  Hans C Dreyer; Satoshi Fujita; Jerson G Cadenas; David L Chinkes; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

3.  Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.

Authors:  Thomas E Jensen; Adam J Rose; Sebastian B Jørgensen; Nina Brandt; Peter Schjerling; Jørgen F P Wojtaszewski; Erik A Richter
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-01-09       Impact factor: 4.310

4.  Effects of a myosin-II inhibitor (N-benzyl-p-toluene sulphonamide, BTS) on contractile characteristics of intact fast-twitch mammalian muscle fibres.

Authors:  G J Pinniger; J D Bruton; H Westerblad; K W Ranatunga
Journal:  J Muscle Res Cell Motil       Date:  2005-04-06       Impact factor: 2.698

Review 5.  Signalling to translation: how signal transduction pathways control the protein synthetic machinery.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

6.  Exercise rapidly increases eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men.

Authors:  Adam J Rose; Christa Broholm; Kristian Kiillerich; Stephen G Finn; Christopher G Proud; Mark H Rider; Erik A Richter; Bente Kiens
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

7.  Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.

Authors:  David L Williamson; Douglas R Bolster; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07       Impact factor: 4.310

8.  Cross bridges account for only 20% of total ATP consumption during submaximal isometric contraction in mouse fast-twitch skeletal muscle.

Authors:  Shi-Jin Zhang; Daniel C Andersson; Marie E Sandström; Håkan Westerblad; Abram Katz
Journal:  Am J Physiol Cell Physiol       Date:  2006-02-15       Impact factor: 4.249

9.  Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle.

Authors:  David L Williamson; Neil Kubica; Scot R Kimball; Leonard S Jefferson
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

10.  Regulation of elongation factor-2 by multisite phosphorylation.

Authors:  N T Redpath; N T Price; K V Severinov; C G Proud
Journal:  Eur J Biochem       Date:  1993-04-15
View more
  33 in total

Review 1.  Muscle protein synthesis in response to nutrition and exercise.

Authors:  P J Atherton; K Smith
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

2.  It's no go for protein when it's all go.

Authors:  Philip J Atherton; Michael J Rennie
Journal:  J Physiol       Date:  2009-04-01       Impact factor: 5.182

3.  Phosphorylation of elongation factor and its kinase expression in Rat m. soleus under early stage of hindlimb unloading.

Authors:  A M Krasniy; E A Lysenko; I B Kozlovskaya; B S Shenkman; Y N Lomonosova
Journal:  Dokl Biochem Biophys       Date:  2014-01-03       Impact factor: 0.788

Review 4.  Molecular regulation of human skeletal muscle protein synthesis in response to exercise and nutrients: a compass for overcoming age-related anabolic resistance.

Authors:  Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

5.  Alcohol impairs skeletal muscle protein synthesis and mTOR signaling in a time-dependent manner following electrically stimulated muscle contraction.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  J Appl Physiol (1985)       Date:  2014-09-25

Review 6.  Cross-talk between protein synthesis, energy metabolism and autophagy in cancer.

Authors:  Lisa M Lindqvist; Kristofferson Tandoc; Ivan Topisirovic; Luc Furic
Journal:  Curr Opin Genet Dev       Date:  2017-11-25       Impact factor: 5.578

Review 7.  Interference between concurrent resistance and endurance exercise: molecular bases and the role of individual training variables.

Authors:  Jackson J Fyfe; David J Bishop; Nigel K Stepto
Journal:  Sports Med       Date:  2014-06       Impact factor: 11.136

8.  Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model.

Authors:  Gabriela P de Oliveira; Jessica R Maximino; Mariana Maschietto; Edmar Zanoteli; Renato D Puga; Leandro Lima; Dirce M Carraro; Gerson Chadi
Journal:  Cell Mol Neurobiol       Date:  2014-01-18       Impact factor: 5.046

9.  Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.

Authors:  Nathan A Stephens; Iain J Gallagher; Olav Rooyackers; Richard J Skipworth; Ben H Tan; Troels Marstrand; James A Ross; Denis C Guttridge; Lars Lundell; Kenneth C Fearon; James A Timmons
Journal:  Genome Med       Date:  2010-01-15       Impact factor: 11.117

10.  Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle.

Authors:  Eija Pöllänen; Vidal Fey; Timo Törmäkangas; Paula H A Ronkainen; Dennis R Taaffe; Timo Takala; Satu Koskinen; Sulin Cheng; Jukka Puolakka; Urho M Kujala; Harri Suominen; Sarianna Sipilä; Vuokko Kovanen
Journal:  Age (Dordr)       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.